TherapeuticsMD (TXMD) Other Working Capital Changes (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Other Working Capital Changes came in at $1000.0 in Q1 2026, up 100.49% YoY from $498.77 in Q1 2025, and up 100.06% on a QoQ basis from -$1.7 million in Q4 2025.
TherapeuticsMD (TXMD) Other Working Capital Changes (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 8 years of Other Working Capital Changes data on file, last reported at $1000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 100.49% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$874000.0 (down 840.68% YoY) and the FY2025 annual result came in at -$1.1 million, down 1098.15% from the prior year.
- Other Working Capital Changes rose to $1000.0 in Q1 2026, from -$1.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $10.1 million in Q2 2022 to a low of -$9.4 million in Q3 2022.
- A 5-year average of -$164235.3 and a median of -$433000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 12950.0% in 2023, down 15700.0% in 2023.
- Tracing TXMD's Other Working Capital Changes over 5 years: stood at $264000.0 in 2022, then sank by 40.15% to $158000.0 in 2023, then sank by 393.67% to -$464000.0 in 2024, then tumbled by 258.84% to -$1.7 million in 2025, then surged by 100.06% to $1000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $1000.0 (Q1 2026), -$1.7 million (Q4 2025), and $217000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -386,000.00 |
| Jun 30, 2026 | -386,000.00 |
| Jun 30, 2026 | -386,000.00 |
| Mar 31, 2026 | -881,000.00 |
| Mar 31, 2026 | -881,000.00 |
| Mar 31, 2026 | -881,000.00 |
| Dec 31, 2025 | -619,000.00 |
| Dec 31, 2025 | -619,000.00 |
| Dec 31, 2025 | -619,000.00 |
| Sep 30, 2025 | -529,000.00 |
| Sep 30, 2025 | -529,000.00 |
| Sep 30, 2025 | -529,000.00 |
| Jun 30, 2025 | -439,000.00 |
| Jun 30, 2025 | -439,000.00 |
| Jun 30, 2025 | -439,000.00 |
| Mar 31, 2025 | -433,000.00 |
| Mar 31, 2025 | -433,000.00 |
| Mar 31, 2025 | -433,000.00 |
| Dec 31, 2024 | -380,000.00 |
| Dec 31, 2024 | -380,000.00 |